These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22221964)

  • 1. [Attention deficit/hyperactivity disorder in childhood and adolescence: from the social construct to pharmacological Calvinism].
    García Campayo J; Alda Díez M; Gascón S
    Aten Primaria; 2012 Mar; 44(3):125-7. PubMed ID: 22221964
    [No Abstract]   [Full Text] [Related]  

  • 2. Does collateral retrospective information about childhood attention-deficit/hyperactivity disorder symptoms assist in the diagnosis of attention-deficit/hyperactivity disorder in adults? Findings from a large clinical sample.
    Breda V; Rovaris DL; Vitola ES; Mota NR; Blaya-Rocha P; Salgado CA; Victor MM; Picon FA; Karam RG; Silva KL; Rohde LA; Bau CH; Grevet EH
    Aust N Z J Psychiatry; 2016 Jun; 50(6):557-65. PubMed ID: 26460329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacological treatment of attention-deficit/hyperactivity disorder in adults].
    Rollini M; Baud P
    Rev Med Suisse; 2008 Jul; 4(165):1638-43. PubMed ID: 18767289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder.
    Visser SN; Lesesne CA; Perou R
    Pediatrics; 2007 Feb; 119 Suppl 1():S99-106. PubMed ID: 17272592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attention deficit hyperactivity disorder in adults: what the non-specialist needs to know.
    Johnson J; Morris S; George S
    Br J Hosp Med (Lond); 2020 Mar; 81(3):1-11. PubMed ID: 32240011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder.
    Özgen H; Spijkerman R; Noack M; Holtmann M; Schellekens ASA; van de Glind G; Banaschewski T; Barta C; Begeman A; Casas M; Crunelle CL; Daigre Blanco C; Dalsgaard S; Demetrovics Z; den Boer J; Dom G; Eapen V; Faraone SV; Franck J; González RA; Grau-López L; Groenman AP; Hemphälä M; Icick R; Johnson B; Kaess M; Kapitány-Fövény M; Kasinathan JG; Kaye SS; Kiefer F; Konstenius M; Levin FR; Luderer M; Martinotti G; Matthys FIA; Meszaros G; Moggi F; Munasur-Naidoo AP; Post M; Rabinovitz S; Ramos-Quiroga JA; Sala R; Shafi A; Slobodin O; Staal WG; Thomasius R; Truter I; van Kernebeek MW; Velez-Pastrana MC; Vollstädt-Klein S; Vorspan F; Young JT; Yule A; van den Brink W; Hendriks V
    Eur Addict Res; 2020; 26(4-5):223-232. PubMed ID: 32634814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attention-deficit/hyperactivity disorder: a life-span perspective.
    Biederman J
    J Clin Psychiatry; 1998; 59 Suppl 7():4-16. PubMed ID: 9680048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic treatment of attention-deficit hyperactivity disorder.
    Greydanus DE
    Indian J Pediatr; 2005 Nov; 72(11):953-60. PubMed ID: 16391451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents.
    ; ; Wolraich M; Brown L; Brown RT; DuPaul G; Earls M; Feldman HM; Ganiats TG; Kaplanek B; Meyer B; Perrin J; Pierce K; Reiff M; Stein MT; Visser S
    Pediatrics; 2011 Nov; 128(5):1007-22. PubMed ID: 22003063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic and pharmacological variances of bipolar disorder versus attention-deficit/hyperactivity disorder.
    Lysne DH; Peterson T; Erickson K; Uriell M
    Am J Psychiatry; 2006 Dec; 163(12):2196; author reply 2196. PubMed ID: 17151181
    [No Abstract]   [Full Text] [Related]  

  • 11. A disorder of anger and aggression: children's perspectives on attention deficit/hyperactivity disorder in the UK.
    Singh I
    Soc Sci Med; 2011 Sep; 73(6):889-96. PubMed ID: 21684645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting substance use disorder using long-term attention deficit hyperactivity disorder medication records in Truven.
    Fouladvand S; Hankosky ER; Bush H; Chen J; Dwoskin LP; Freeman PR; Henderson DW; Kantak K; Talbert J; Tao S; Zhang GQ
    Health Informatics J; 2020 Jun; 26(2):787-802. PubMed ID: 31106686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical management of attention deficit hyperactivity disorder.
    Voeller KK
    J Child Neurol; 1991; 6 Suppl():S51-67. PubMed ID: 1672134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attention-deficit/hyperactivity disorder: advances in diagnostic and therapeutic approaches.
    DelBello MP
    J Clin Psychiatry; 2008 Jan; 69(1):130. PubMed ID: 18312047
    [No Abstract]   [Full Text] [Related]  

  • 15. Association Between Childhood to Adolescent Attention Deficit/Hyperactivity Disorder Symptom Trajectories and Late Adolescent Disordered Eating.
    Yilmaz Z; Javaras KN; Baker JH; Thornton LM; Lichtenstein P; Bulik CM; Larsson H
    J Adolesc Health; 2017 Aug; 61(2):140-146. PubMed ID: 28734322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic challenges of attention-deficit hyperactivity disorder with substance use disorders.
    Bukstein OG
    Expert Rev Neurother; 2006 Apr; 6(4):541-9. PubMed ID: 16623653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing attention-deficit/hyperactivity disorder in primary care: a systematic analysis of roles and challenges.
    Power TJ; Mautone JA; Manz PH; Frye L; Blum NJ
    Pediatrics; 2008 Jan; 121(1):e65-72. PubMed ID: 18166546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis of attention-deficit hyperactivity disorder in childhood and adolescence].
    Romanos M; Schwenck C; Walitza S
    Nervenarzt; 2008 Jul; 79(7):782-90. PubMed ID: 18548224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attention-deficit/hyperactivity disorder: etiology and pharmacotherapy.
    Noorbala AA; Akhondzadeh S
    Arch Iran Med; 2006 Oct; 9(4):374-80. PubMed ID: 17061613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological management of attention-deficit hyperactivity disorder in adolescents: special considerations.
    Hazell P
    CNS Drugs; 2007; 21(1):37-46. PubMed ID: 17190528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.